Orally administered cannabidiol does not produce false-positive tests for Δ⁹ -tetrahydrocannabinol on the Securetec DrugWipe® 5S or Drager DrugTest® 5000.

ABSTRACT: Many jurisdictions use point-of-collection (POC) oral fluid testing devices to identify driving under the influence of cannabis, indexed by the presence of Δ⁹ -tetrahydrocannabinol (THC), an intoxicating cannabinoid, in oral fluid. Although the use of the non-intoxicating cannabinoid, cannabidiol (CBD), is not prohibited among drivers, it is unclear whether these devices can reliably distinguish between CBD and THC, which have similar chemical structures. This study determined whether orally administered CBD produces false-positive tests for THC on standard, POC oral fluid testing devices. In a randomised, double-blind, crossover design, healthy participants (n = 17) completed four treatment sessions involving the administration of either placebo or 15-, 300- or 1500-mg pure CBD

SUBMITTER: McCartney D 

PROVIDER: S-EPMC9292716 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature